These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cidofovir approved.
    Journal: PI Perspect; 1996 Sep; (No 19):14-5. PubMed ID: 11363898.
    Abstract:
    The Food and Drug Administration (FDA) in 1996 approved cidofovir (Vistide) for treatment of cytomegalovirus (CMV) retinitis. The decision was based on two studies showing that immediate cidofovir therapy can delay CMV retinitis progression. While cidofovir has a narrow dose range, it also does not have significant side effects if used properly. Because of this, the use of cidofovir for CMV retinitis treatment is considered an attractive alternative. Gilead Sciences has set up a Patient Assistance Program for cidofovir.
    [Abstract] [Full Text] [Related] [New Search]